443 related articles for article (PubMed ID: 22707222)
1. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
Kreuz J; Horlbeck F; Schrickel J; Linhart M; Fimmers R; Mellert F; Nickenig G; Schwab JO
Clin Cardiol; 2012 Sep; 35(9):575-9. PubMed ID: 22707222
[TBL] [Abstract][Full Text] [Related]
2. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
3. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
[TBL] [Abstract][Full Text] [Related]
6. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
7. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
Klein H; Auricchio A; Reek S; Geller C
Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
J Am Coll Cardiol; 2018 Oct; 72(14):1653-1676. PubMed ID: 29097297
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
[TBL] [Abstract][Full Text] [Related]
10. Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.
Zhang Y; Guallar E; Blasco-Colmenares E; Butcher B; Norgard S; Nauffal V; Marine JE; Eldadah Z; Dickfeld T; Ellenbogen KA; Tomaselli GF; Cheng A
J Am Coll Cardiol; 2015 Aug; 66(5):524-31. PubMed ID: 26227190
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
[TBL] [Abstract][Full Text] [Related]
12. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators.
Sroubek J; Matos J; Locke A; Kaplinskiy V; Levine YC; Shen C; Buxton AE
Heart Rhythm; 2021 Jan; 18(1):71-78. PubMed ID: 32866691
[TBL] [Abstract][Full Text] [Related]
14. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
[TBL] [Abstract][Full Text] [Related]
15. Implantable Cardioverter-Defibrillator Placement for Primary Prevention in 2,346 Patients: Predictors of One-Year Survival.
Merchant FM; Desai Y; Addish MA; Kelly K; Casey M; Goyal A; Leon AR; El-Chami MF
Tex Heart Inst J; 2018 Aug; 45(4):221-225. PubMed ID: 30374229
[TBL] [Abstract][Full Text] [Related]
16. Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.
Rodríguez-Zanella H; Muraru D; Secco E; Boccalini F; Azzolina D; Aruta P; Surkova E; Genovese D; Cavalli G; Sammarco G; Ruozi N; Tenaglia RM; Calvillo-Argüelles O; Palermo C; Iliceto S; Badano LP
JACC Cardiovasc Imaging; 2019 Oct; 12(10):1917-1926. PubMed ID: 30219408
[TBL] [Abstract][Full Text] [Related]
17. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
[TBL] [Abstract][Full Text] [Related]
19. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
